Improving the Therapeutic Index of Topically Applied Ocular Drugs
- 1 April 1984
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 102 (4) , 551-553
- https://doi.org/10.1001/archopht.1984.01040030429017
Abstract
• Nasolacrimal occlusion (NLO) and eyelid closure are simple techniques that not only increase the ocular bioavailability of topically applied ocular drugs but also reduce the probability of adverse systemic effects. Each serves to improve the therapeutic index. Subsequent to the application of 0.5% timolol maleate, the effects of NLO and eyelid closure were compared with the effects of no procedures. In this experiment, systemic drug absorption in normal volunteers was reduced more than 60%. Measurements were made by radioimmunoassay of timolol in blood plasma. In addition, the diminution of fluorescein in the anterior chamber was observed for three hours following direct application to the lower cul-de-sac. Results indicate a lower fluorescein concentration and a shorter duration of fluorescence in the absence of either experimental technique. Both NLO and eyelid closure seem to be safe, simple, and effective procedures that could minimize dosage requirements, as well as side effects.This publication has 5 references indexed in Scilit:
- Evaluation of a radioreceptor assay for beta-adrenoceptor antagonists in plasmaEuropean Journal of Clinical Pharmacology, 1980
- Use of a Xenon Flash Tube As the Excitation Source in a New Slit-Lamp FluorophotometerAmerican Journal of Ophthalmology, 1978
- The Lacrimal Secretory System and its TreatmentAmerican Journal of Ophthalmology, 1966
- A new objective fluorophotometerExperimental Eye Research, 1963
- FATALITIES FOLLOWING TOPICAL APPLICATION OF LOCAL ANESTHETICS TO MUCOUS MEMBRANESJAMA, 1956